PA8426801A1 - Composiciones farmaceuticas para el tratamiento de la rinitis. - Google Patents

Composiciones farmaceuticas para el tratamiento de la rinitis.

Info

Publication number
PA8426801A1
PA8426801A1 PA19978426801A PA8426801A PA8426801A1 PA 8426801 A1 PA8426801 A1 PA 8426801A1 PA 19978426801 A PA19978426801 A PA 19978426801A PA 8426801 A PA8426801 A PA 8426801A PA 8426801 A1 PA8426801 A1 PA 8426801A1
Authority
PA
Panama
Prior art keywords
rhinitis
treatment
pharmaceutical compositions
individual
pseudoefedrina
Prior art date
Application number
PA19978426801A
Other languages
English (en)
Inventor
De Venne Herman Van
Jean-Pierre Martin
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24521774&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8426801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of PA8426801A1 publication Critical patent/PA8426801A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CANTIDAD TERAPEUTICAMENTE EFICAZ DE UNA MEZCLA FORMADA ESENCIALMENTE POR (I) COMPUESTO SELECCIONADO DE PSEUDOEFEDRINA, FENILPROPANOLAMINA Y FENILEFRINA, UN ISOMERO OPTICO INDIVIDUAL O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA, Y (II) AL MENOS UN COMPUESTO SELECCIONADO DEL ACIDO 2- (4-(DIFENILMETIL)-1- PIPERACINIL)-ACETICO O DERIVADOS AMIDICOS, UN ISOMERO OPTICO INDIVIDUAL O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO.
PA19978426801A 1996-04-08 1997-04-08 Composiciones farmaceuticas para el tratamiento de la rinitis. PA8426801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/629,144 US6469009B1 (en) 1996-04-08 1996-04-08 Pharmaceutical compositions for the treatment of rhinitis

Publications (1)

Publication Number Publication Date
PA8426801A1 true PA8426801A1 (es) 2000-05-24

Family

ID=24521774

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19978426801A PA8426801A1 (es) 1996-04-08 1997-04-08 Composiciones farmaceuticas para el tratamiento de la rinitis.

Country Status (10)

Country Link
US (2) US6469009B1 (es)
AU (1) AU723364B2 (es)
BR (1) BR9701686A (es)
CO (1) CO4820432A1 (es)
GB (1) GB2311940B (es)
GT (1) GT199700037A (es)
NZ (1) NZ314521A (es)
PA (1) PA8426801A1 (es)
PE (1) PE42598A1 (es)
SV (1) SV1997000026A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
US6651816B2 (en) * 2001-05-04 2003-11-25 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
KR20090029314A (ko) * 2001-06-28 2009-03-20 유씨비 파쉼 소시에떼아노님 세티리진 및 슈도에페드린을 포함하는 정제
US7403981B2 (en) * 2002-01-04 2008-07-22 Quicksilver Technology, Inc. Apparatus and method for adaptive multimedia reception and transmission in communication environments
UA76837C2 (uk) * 2002-03-13 2006-09-15 Еррей Байофарма Інк. N3 алкіловані похідні бензімідазолу як інгібітори мек
CA2489991A1 (en) * 2002-06-21 2003-12-31 Dr. Reddy's Laboratories Limited Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl|ethoxy| acetic acid dihydrochloride (levocetririzine dihydrochloride)
AU2003249881A1 (en) 2002-07-02 2004-01-23 Ucb Farchim S.A. Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis
JP4303925B2 (ja) * 2002-08-19 2009-07-29 篠田プラズマ株式会社 金属酸化膜の形成方法及びガス放電管の２次電子放出膜形成方法
US20060122194A1 (en) * 2002-12-06 2006-06-08 Ucb Farchim S.A. Tablet comprising efletirizine and pseudoephedrine
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US20100172984A1 (en) * 2006-06-06 2010-07-08 Bijay Kumar Padhi tablet dosage form comprising cetirizine and pseudoephedrine
PL2041088T3 (pl) 2006-06-28 2014-07-31 Amgen Inc Inhibitory transportera-1 glicyny
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20090062305A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched cetirizine
US20090082364A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levocedtirizine
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
CA2748728C (en) * 2009-01-05 2017-01-03 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4800162A (en) 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5057427A (en) 1988-04-07 1991-10-15 Sepracor, Inc. Method for resolution of stereoisomers
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
IL98179A0 (en) * 1990-05-21 1992-06-21 Norwich Eaton Pharma Pharmaceutical compositions containing phenylpropanolamine
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
ATE170749T1 (de) 1992-09-24 1998-09-15 Sepracor Inc Verwendung von (-) cetirizin zur behandlung allergischer rhinitis und und asthma
EP0885611A3 (en) 1992-09-24 1999-01-07 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
JPH08502288A (ja) 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
WO1994025009A1 (en) 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
BR9407414A (pt) 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteroide de ácido propiônico e pelo menos um descongestionante um expectorante um anti-histamina e um antitussivo

Also Published As

Publication number Publication date
AU723364B2 (en) 2000-08-24
US6469009B1 (en) 2002-10-22
GB2311940B (en) 2000-07-19
MX9702532A (es) 1998-06-30
GB2311940A (en) 1997-10-15
AU1774097A (en) 1997-10-16
NZ314521A (en) 1999-09-29
US6489329B2 (en) 2002-12-03
BR9701686A (pt) 1998-11-10
US20010020023A1 (en) 2001-09-06
GB9706842D0 (en) 1997-05-21
CO4820432A1 (es) 1999-07-28
GT199700037A (es) 1998-09-26
PE42598A1 (es) 1998-08-17
SV1997000026A (es) 1998-11-10

Similar Documents

Publication Publication Date Title
PA8426801A1 (es) Composiciones farmaceuticas para el tratamiento de la rinitis.
DK0863891T3 (da) (Methylsulfonyl)phenyl-2-(5H)-furanoner som COX2-inhibitorer
UY24816A1 (es) Sulfonamidas agonistas de prostaglandinas para la prevención y restauración de la masa ósea
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
ATE297203T1 (de) Antithrombotische mitteln
NO955256L (no) Fenylheterosykluser som syklooksygenase-2-inhibitorer
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
DK0828724T3 (da) 5-oxygenerede diaryl-2-(5H)-furanoner som COX-2-inhibitorer
UY26977A1 (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO991494L (no) <beta>-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
GT199900015A (es) Procedimiento para tratar la insuficiencia cardiaca
AR009358A1 (es) Compuesto espirociclico inhibidor de la metaloproteasa
ES2171590T3 (es) Composicion farmaceutica para el tratamiento de rinitis agudas, que contiene un simpatomimetico y pantotenol y/o acido pantotenico.
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
ES2179523T3 (es) Metodo para aumentar la biodisponibilidad de la fexofenadina y sus derivados.
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.